Nivolumab with carboplatin, paclitaxel, and bevacizumab for first-line treatment of advanced nonsquamous non-small-cell lung cancerShunichi Sugawara, Kazuhiko Nakagawa, Naoki Inui et al.|Annals of Oncology|2021Cited by 202
OA01.04 Five-Year Survival in Patients with ES-SCLC Treated with Atezolizumab in IMpower133: Imbrella a Extension Study ResultsStephen V. Liu, Martin Reck, Rafał Dziadziuszko et al.|Journal of Thoracic Oncology|2023Cited by 36